1 / 16

Cardiotropic Drugs

Cardiotropic Drugs. Cardiotropic Drugs. used for Congestive Heart Failure and for Cardiac Arrhythmia. I. Digitalis Glycosides. Digoxin Digitoxin. Digoxin. Half-life 35 – 40 h Therapeutic Range 0.5 – 2 ng/mL Toxic Level >2 ng/mL Mechanism of Action

klewis
Télécharger la présentation

Cardiotropic Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiotropic Drugs

  2. Cardiotropic Drugs • used for Congestive Heart Failure and for Cardiac Arrhythmia

  3. I. Digitalis Glycosides • Digoxin • Digitoxin

  4. Digoxin • Half-life 35 – 40 h • Therapeutic Range 0.5 – 2 ng/mL • Toxic Level >2 ng/mL • Mechanism of Action • Functions by inhibiting membrane Na+, K+ -ATPase (causes a decrease in intracellular potassium, resulting in increased intracellular calcium in cardiac contractility)

  5. Toxic Adverse Effects • Nausea • Vomiting • Visual disturbances • Cardiac effects (premature ventricular contractions – PVC and atrioventricular node blockage) • Route of Administration (oral)

  6. Important comments • elimination of digoxin occurs primarily by renal filtration of the plasma free form • in circulation, 25% is protein-bound and the rest is sequestered into muscle cells • its therapeutic actions and toxicities is influenced by the concentration of serum electrolytes (low serum potassium and magnesium potentiate digoxin actions) • Thyroid status also influence the action of digoxin: • Hyperthyroid patients: resistance • Hypothyroid patients: more sensitive

  7. Digitoxin • Half-life 4 – 6 h • Therapeutic Range 9-25 ng/mL • Toxic Level >25 ng/mL • Important comments • Converted to active metabolite (digoxin) in the liver

  8. II. Procainamide (Prontesyl) • Half-life 3 – 5 h • Therapeutic Range 4 – 10 ng/mL • Toxic Level >12 ng/mL • Route of Administration (oral)

  9. Important comments • Undergoes N-acetylation in the liver to form N-acetylprocainamide (NAPA) which is the active metabolite • Toxic side effects related to Systemic Lupus Erythematosus (SLE) • Gastrointestinal absorption is rapid and complete • Absorbed procainamide is about 20% bound to plasma proteins • Its active metabolite can be measured by immunoassay

  10. III. Quinidine • Half-life 5 – 12 h • Therapeutic Range 2.3 – 5 ng/mL • Toxic Level >5 ng/mL • Toxic Adverse Effects • Nausea • Vomiting • Abdominal discomfort • Route of Administration (oral)

  11. Important comments • Measured fluorometrically (common) • May also be determined by chromatography and immunoassay • Undergoes hydroxylation in the liver • Two most common formulations: • Quinidine sulfate (gastrointestinal absorption is complete and rapid) • Quinidine gluconate • Absorbed quinidine is 70 – 80% bound to serum proteins • Elimination is through hepatic metabolism

  12. IV. Lidocaine (Xylocaine) • Half-life 2 h • Therapeutic Range 1.2 – 5.5 µg/mL • Toxic Level >5.5 µg/mL • Important comments • A local anesthetic • Undergoes N-dealkylation in the liver • Not protein-bound • Not stored in tissues

  13. V. Propanolol (Indiral) • Half-life 3 h • Therapeutic Range 50 – 100 ng/mL • Toxic Level >100 ng/mL • Important comments • Toxic effect: Raynaud’s type

  14. VI. Disopyramide • Important comments • Commonly used as quinidine substitute when quinidine adverse effects are excessive • Orally administered • Gastrointestinal is complete and rapid • Eliminated by renal filtration, and to a lesser extent, by hepatic metabolism

  15. Toxic Adverse Effects • Anticholinergic effects (>4.5 µg/mL) • Dry mouth • Constipation • Cardiac Effects (>10 µg/mL) • Bradycardia • Atrioventricular node blockage

  16. Thank you for listening!

More Related